EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic Testing in Hypertrophic Cardiomyopathy: Expanding Global Representation While Refining Interpretation

Fernando Rabioglio Giugni

Arquivos Brasileiros de Cardiologia · 2026 · 123 (2)

DOI: 10.36660/abc.20260157i ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arquivos Brasileiros de Cardiologia, 2026. Verfasst von Fernando Rabioglio Giugni. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertrophic cardiomyopathy (HCM) represents a paradigmatic example of how genetics has transformed contemporary cardiovascular medicine. Advances in sequencing technologies over the past two decades have substantially expanded molecular diagnosis, family screening, and risk stratification strategies. However, much of the current evidence derives from North American and European cohorts, with comparatively limited representation of Latin American populations. In this context, studies describing the genetic and clinical characteristics of Brazilian patients are particularly important, both to broaden global understanding of HCM and [...]

Zitieren

APA

Giugni, F. R. (2026). Genetic Testing in Hypertrophic Cardiomyopathy: Expanding Global Representation While Refining Interpretation. Arquivos Brasileiros de Cardiologia, 123(2). https://doi.org/10.36660/abc.20260157i

Vancouver

Giugni FR. Genetic Testing in Hypertrophic Cardiomyopathy: Expanding Global Representation While Refining Interpretation. Arquivos Brasileiros de Cardiologia. 2026;123(2). doi:10.36660/abc.20260157i

BibTeX
@article{Giugni2026,
  author = {Giugni, Fernando Rabioglio},
  title = {Genetic Testing in Hypertrophic Cardiomyopathy: Expanding Global Representation While Refining Interpretation},
  journal = {Arquivos Brasileiros de Cardiologia},
  year = {2026},
  volume = {123},
  number = {2},
  doi = {10.36660/abc.20260157i}
}
Kostenlos starten →